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1276-82. The current status of fetal cardiac surgery is similar to the field ofinfant heart surgery 50 years ago, when it was clear that correctionof certain congenital defects would provide great benefit, but therewas no safe and effective method to gain access to the heart.However, with the development of cardiopulmonary bypass (CPB)equipment and techniques, intraoperative access to the heart became
possible. Moreover, surgeons developed an understanding of the pathophysiologic
responses of the child to these techniques and learned how to protect the myocar-
dium, as well as the patient, during open cardiac repair.1,2 This allowed postnatal
cardiac surgery to be done safely and effectively. If similar “low-risk” techniques,
understanding, and equipment existed for the fetus, there would be little argument
that fetal cardiac surgery would be preferable for certain congenital lesions. How-
ever, little is known about the pathophysiologic effect of surgical intervention or
CPB on the developing fetus. As a consequence, many of the surgical techniques
developed over the past 50 years for patients with cardiac disease, including those
of extracorporeal circulation and myocardial protection, must be redeveloped before
application to the fetus.
Early experimental work on fetal cardiovascular interventions demonstrated it
was technically possible to place the fetal lamb on and separate from CPB.3,4
Nevertheless, most animals died within hours as a result of placental dysfunction
after a marked increase in placental vascular resistance. Moreover, even when
placental dysfunction was prevented, the post-CPB fetus routinely had progressive
metabolic acidosis as a result of decreased cardiac output, leading to late death.3,5,6
These studies clearly establish that the major limitation to successful clinical fetal
cardiac surgery would not be technical but related to the pathophysiologic responses
of the fetus to various forms of intervention.
Physiologic challenges to fetal cardiac surgery relate both to CPB management
and optimization of protection of the fetal heart. It makes no sense to perform an
intervention to alter the flow dynamics of the myocardium only to end up with heart
muscle that is severely damaged and unable to support the circulation. Protection of
the fetal heart is complicated by immature calcium regulation and energy use,
decreased tolerance to ischemia, limited coronary vascular response, an impaired
length-tension relationship, and a reduced cardiac and inotropic reserve compared
with that of the mature infant.3,4,6-9 Moreover, the clinical fetal heart is likely to be
further stressed by the structural abnormality that requires intervention, thus making
it even less tolerant to ischemia than the unperturbed (morphologically normal) fetal
heart used in experimental studies. This makes complete recovery of myocardial
function in the experimental setting absolutely critical before fetal intervention is
undertaken clinically.
As an initial step, Malhotra and associates6 used an isolated fetal heart prepara-
tion in an attempt to examine fetal myocardial protection without the complicating
factor of the placenta because fetal death and myocardial failure can be caused by
either myocardial or placental dysfunction.3-6 Although this seems like an excellent
solution, an isolated heart preparation has its own inherent problems, and the results
might be not always be applicable to the clinical setting. For example, bronchial
blood flow and noncoronary collateral flow are both absent in the isolated heart
preparation. Bronchial blood flow may actively rewarm the heart, whereas noncoro-
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nary collateral flow helps wash out cardioplegic solutuion,
thereby changing the cellular environment during myocar-
dial arrest.1,2,10,11 Several cardioplegic constituents (ie, cal-
cium and glucose) that have been found to be protective or
deleterious in the isolated heart have been found to have the
opposite effect in the intact (in vivo) heart as a result of
cardioplegic washout.1,2,10,11 One might also question
whether the fetal heart is damaged by excision alone be-
cause baseline measurements were not taken until the heart
was placed in an isolated preparation. Moreover, the authors
used a crystalloid (Krebs-Henseleit) solution containing
high calcium, the harbinger to damage, to perfuse their
isolated heart preparation.2,10 This can profoundly alter the
coronary vascular response and calcium loading, particu-
larly after ischemia.1,2,10,12 This might be especially impor-
tant during the period of ventricular fibrillation, as well as
after reperfusion after ischemia in both groups. For exam-
ple, is fetal subendocardial perfusion improved or worsened
during ventricular fibrillation in the presence of crystalloid
perfusion? A blood perfused model would have been more
physiologic and alleviated some of these concerns.10-12
Nevertheless, the intact (in vivo) animal is still preferable
because differences will always remain, and no interven-
tions should be applied clinically until proved successful in
the intact animal.
Methods of myocardial protection must be evaluated in
the fetal heart and not simply extrapolated from adult and
infant studies because the immature fetal myocardium
might react quite differently to various interventions. This
investigation by Malhotra and associates6 is a very impor-
tant introduction because it is one of the first attempts to
address the issue of fetal myocardial protection, and there-
fore its simplicity seems justified. However, the myocar-
dium must be optimally and fully preserved for fetal surgery
to be successful. Myocardial dysfunction likely dooms the
fetus to death before delivery because the stress of CPB
alone (without myocardial ischemia) uniformly leads to
fetal death from progressive metabolic acidosis caused by
low cardiac output.3,5 An injured heart will only exacerbate
this post-CPB stress. Furthermore, even if the fetus sur-
vives, when born, it will be left with a heart that is destined
to fail despite its structural normality.
Malhotra and associates6 compared crystalloid cardiople-
gia with ventricular fibrillation in hearts subjected to only
30 minutes of cardiac arrest. They concluded that the 2
methods of protection are similar and that ventricular fibril-
lation is therefore probably preferable because it is “sim-
pler.” I am not sure this is the correct question because the
goal should be avoidance of myocardial injury and not
simplicity of technique, especially because longer periods
of ischemia might be necessary to correct certain lesions.
Moreover, further analysis of their data is concerning. De-
spite only 30 minutes of ischemic arrest, recovery of end-
systolic elastance (contractility) was markedly reduced in
both groups, as was diastolic compliance and overall myo-
cardial function (preload recruitable stroke work). Further-
more, the increase in postarrest myocardial water was ex-
tensive and resembles levels seen only in neonatal and
infant hearts that have sustained a severe and usually irre-
versible injury.1,2,10,11 This calls into question the efficacy
of both methods of protection because the damage is quite
profound for such a short period of ischemia.
Many surgeons previously used the technique of ventric-
ular fibrillation with continuous perfusion because it was
simple. However, they found, to their dismay, that hearts
(especially those with hypertrophy) that were fibrillated
during extracorporeal circulation frequently sustained some
degree of ischemic damage, especially to the vulnerable
subendocardial region.2 Although a single dose of crystal-
loid cardioplegic solution and ventricular fibrillation might
simplify fetal cardiac surgery, the ultimate goal of myocar-
dial protection is not simplicity. As with the technical as-
pects of the repair, the primary objective is use of the
optimal strategy. Integration of surgical techniques is usu-
ally required to perform the best possible operation. Opti-
mal myocardial protection also requires integration of
various techniques and strategies.1,2 Most surgeons
would not abandon a complex surgical procedure that
was proved superior solely because of its lack of sim-
plicity. Likewise, we should not choose a protection
strategy for its simplicity unless it provides optimal and
complete myocardial protection. Optimal myocardial
protection is as important as an excellent technical repair
to achieve a good long-term outcome with surgical cor-
rection. Although the surgeon might desire simplicity, the
patient is only concerned with success.
In conclusion, the authors are to be commended for this
pioneering study in the new frontier of fetal cardiac surgery.
However, one must look with caution both to their model
and their results. Success must be achieved in an appropriate
clinical (in vivo) model before clinical application. More-
over, no matter what the risk of subsequent repair, unless
fetal surgery can be done safely with minimal myocardial
injury and complete preservation of cardiac function, we
have simply traded one problem for another (ie, a heart with
normal structure for one with myocardial dysfunction).
Hopefully, this important initial study will spur others to
continue investigations in this field so that fetal cardiac
surgery can become a reality in the future. Although the task
seems daunting, it is probably no more daunting than infant
surgery appeared to those surgeons 50 years ago. If we show
the same perseverance and dedication as our predecessors,
there is no reason this new frontier cannot be tamed in the
same way.
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